The request references two recent settlements with the office of New York Attorney General Eric Schneiderman and Anthem and Cigna ending preauthorization for the treatment.
“The AMA believes that attorneys general can reach the same agreement with all payers, and we pledge our public support in making that happen,” James Madara, MD, CEO and executive vice president of the AMA, wrote on behalf of the association.
Dr. Madara said manual and time-consuming processes used in preauthorization policies interrupt care for patients with opioid use disorder. “There is no medical, policy or other reason[,] for payers to use prior authorization for MAT, and we hope that New York’s efforts will be the first of many similar ones across the nation,” he added.
More articles on opioids:
CDC issues report on string of fentanyl overdoses in Connecticut: 5 takeaways
3 ways repealing ACA could exacerbate the opioid epidemic
Maryland governor proposes opioid prescription restrictions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
